Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Oxidative stress (OS) is a hallmark of Alzheimer's disease (AD), yet the cell type-specific mechanisms remain unclear. We analyzed a single-cell RNA sequencing (scRNA-seq) dataset to assess OS-related features in AD. OS scores were calculated using multiple algorithms, and differential expression, enrichment, protein-protein interaction (PPI) network, and machine learning (ML) approaches were appl...
Machine learning enables scalable quantification of neuropathology, offering deeper phenotyping of Alzheimer's disease (AD). In this validation study, we quantified amyloid-beta (Aβ) deposits, evaluating multiple brain regions across institutions, and evaluated associations with clinical, demographic, and genetic factors in persons pathologically diagnosed with AD. All linear models were adjusted ...
Alzheimer's disease (AD) is a prevalent neurodegenerative disorder affecting millions worldwide. Electroencephalography (EEG), a non-invasive, cost-ef...
Artificial intelligence (AI) is transforming biomarker discovery in neurology by overcoming key limitations of conventional approaches that are often ...
BACKGROUND: The hippocampus is a key brain region and biomarker for Alzheimer's disease (AD). Accurate automated hippocampal segmentation is essential...
Accurate and early diagnosis of Alzheimer's disease (AD) remains a major clinical challenge, particularly in distinguishing mild cognitive impairment ...
Alzheimer's Disease (AD) is a degenerative disorder of the brain that causes a gradual loss of cognitive function. The cholinergic hypothesis suggests...
BackgroundAlzheimer's disease (AD) affects 55 million people worldwide, projected to reach 139 million by 2050; yet, most machine learning (ML)-based ...
BACKGROUND: Caregivers supporting individuals with Alzheimer disease and related dementias (AD/ADRD) frequently encounter prolonged emotional strain, ...
BACKGROUND: Alzheimer disease and related dementias are increasing worldwide, with early detection during the mild cognitive impairment (MCI) stage cr...
Digital technologies have the potential to transform early childhood development (ECD) interventions by delivering personalized support at scale. We c...
To investigate a non-invasive magnetic resonance imaging (MRI)-based method for detecting amyloid-β (Aβ) protein deposition in different brain regions...
Tau-protein aggregation is a central pathological feature of Alzheimer's disease, so blocking fibril growth is an attractive therapeutic goal. We cura...
Generative artificial intelligence (AI) technologies, capable of producing original text, images, audio, and video, are increasingly embedded in child...
Symptoms of anxiety are known to be triggered by a range of life context factors including early life trauma, poor sleep quality, infrequent exercise,...
BackgroundAlzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by amyloid-β plaques, neurofibrillary tangles, and synapt...
Dementia is a progressive neurodegenerative disorder that severely impacts cognitive functions and daily living, especially in aging populations. Amon...
Infants' time spent in different body positions varies substantially within a day: lying supine on their backs, crawling or playing while prone on the...